CervoMed Inc (NASDAQ: CRVO)’s stock price has increased by 131.14 compared to its previous closing price of 2.36. However, the company has seen a 152.55% increase in its stock price over the last five trading sessions. globenewswire.com reported 2025-03-10 that A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p
Is It Worth Investing in CervoMed Inc (NASDAQ: CRVO) Right Now?
Additionally, the 36-month beta value for CRVO is 1.73. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 4 rating it as “hold,” and 1 rating it as “sell.”
The public float for CRVO is 5.35M and currently, short sellers hold a 16.91% ratio of that float. The average trading volume of CRVO on March 12, 2025 was 240.89K shares.
CRVO’s Market Performance
CRVO stock saw an increase of 152.55% in the past week, with a monthly gain of 149.09% and a quarterly increase of -54.20%. The volatility ratio for the week is 8.95%, and the volatility levels for the last 30 days are 7.38% for CervoMed Inc (CRVO). The simple moving average for the last 20 days is 128.75% for CRVO stock, with a simple moving average of -50.46% for the last 200 days.
CRVO Trading at 137.89% from the 50-Day Moving Average
After a stumble in the market that brought CRVO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.32% of loss for the given period.
Volatility was left at 7.38%, however, over the last 30 days, the volatility rate increased by 8.95%, as shares surge +184.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +152.50% upper at present.
During the last 5 trading sessions, CRVO rose by +180.56%, which changed the moving average for the period of 200-days by -68.12% in comparison to the 20-day moving average, which settled at $2.41. In addition, CervoMed Inc saw 133.12% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CRVO starting from ELDER WILLIAM ROBERT, who purchase 1,000 shares at the price of $18.16 back on Aug 27 ’24. After this action, ELDER WILLIAM ROBERT now owns 1,267 shares of CervoMed Inc, valued at $18,160 using the latest closing price.
Stock Fundamentals for CRVO
Current profitability levels for the company are sitting at:
- -1.66 for the present operating margin
- 0.3 for the gross margin
The net margin for CervoMed Inc stands at -1.47. The total capital return value is set at -0.3. Equity return is now at value -43.28, with -39.22 for asset returns.
Currently, EBITDA for the company is -2.17 million with net debt to EBITDA at 0.58. When we switch over and look at the enterprise to sales, we see a ratio of 4.73. The receivables turnover for the company is 30.77for trailing twelve months and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 15.04.
Conclusion
In conclusion, CervoMed Inc (CRVO) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
